glp-1 drugs mounjaro Tirzepatide (Mounjaro) People take GLP-1 drugs like
Description
Litigation continues alleging the manufacturer of Wegovy (Novo Nordisk) knew the risk of harm to patients and failed to properly warn consumers
Most common long-term side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation
In addition, to reduce the bias caused by the data sources and to improve the statistical efficacy, we performed Meta-analysis of the two results with the total effect as the final result
It is not an exaggeration to say entire industries have been built on the back of the obesity epidemic, its drivers and its consequences
They affect 20%30% of patients and usually cease during long-term therapy after a few weeks
